Creatine supplementation raises ATP levels in dendritic cells, which enables these cells to perform energy-demanding tasks like presenting antigens and releasing cytokines when nutrients are limited due to competition with tumor cells.
See the scientific wording
Creatine supplementation increases ATP levels in dendritic cells, supporting their energy-intensive functions including antigen presentation and cytokine signaling under conditions of nutrient competition with tumor cells.
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman
Creatine helps immune cells in tumors stay energized so they can better alert the body’s cancer-fighting troops, even when food is scarce. The study showed that giving creatine made these immune cells work better and slowed tumor growth.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Dendritic cells in tumors take up creatine from their surroundings, convert it into a high-energy storage molecule, and use it to keep their ATP levels high even when food is scarce. This energy allows them to display tumor fragments to T cells and send signals that activate T cells to attack cancer cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Creatine supplementation raises ATP levels in dendritic cells, which enables these cells to perform energy-demanding tasks like presenting antigens and releasing cytokines when nutrients are limited due to competition with tumor cells.
Mechanism
1 studyDendritic cells in tumors grab creatine to make more energy, which lets them show cancer fragments to T cells and turn them into attackers. This keeps the immune system fighting even when food is scarce.
Dendritic cells in tumors take up creatine from their surroundings, convert it into a high-energy storage molecule, and use it to keep their ATP levels high even when food is scarce. This energy allows them to display tumor fragments to T cells and send signals that activate T cells to attack cancer cells.
Dendritic cells within nutrient-depleted tumor environments upregulate expression of the creatine transporter SLC6A8 to increase creatine uptake from the extracellular space
Internalized creatine is phosphorylated to phosphocreatine by creatine kinase, creating a high-energy phosphate reservoir that rapidly regenerates ATP during periods of high energy demand
Elevated ATP levels sustain energy-intensive processes including antigen processing, upregulation of costimulatory molecules, and secretion of inflammatory cytokines
Enhanced dendritic cell activation enables efficient presentation of tumor antigens to T cells and delivery of co-stimulatory signals that drive T cell proliferation and effector function
Activated T cells produce cytotoxic molecules and inflammatory cytokines that target and eliminate tumor cells
Evidence from Studies
Supporting (1)
Community contributions welcome
Unknown Title
Creatine helps immune cells in tumors stay energized so they can better alert the body’s cancer-fighting troops, even when food is scarce. The study showed that giving creatine made these immune cells work better and slowed tumor growth.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Creatine Supplementation Effects on Dendritic Cell ATP Levels and Function in Tumor Microenvironments
Systematic review and meta-analysis of all published in vitro, animal, and human studies comparing dendritic cell ATP levels, antigen presentation, and cytokine signaling following creatine supplementation versus control under low-nutrient conditions mimicking tumor microenvironments.
Double-Blind RCT of Creatine vs Placebo on Dendritic Cell ATP and Function in Humans with Solid Tumors
Double-blind, placebo-controlled trial in adult humans with solid tumors, comparing oral creatine supplementation to placebo for 8 weeks, measuring ATP levels, antigen presentation capacity, and cytokine secretion in isolated peripheral dendritic cells.
Prospective Cohort Study of Creatine Intake and Dendritic Cell Function in Cancer Patients
Prospective cohort study following cancer patients over 6–12 months, measuring habitual creatine intake via dietary logs and serially assessing dendritic cell ATP content, antigen presentation, and cytokine production in peripheral blood samples.
In Vitro Analysis of Creatine on ATP Levels and Function in Human Dendritic Cells Under Nutrient Deprivation
In vitro experiment exposing human monocyte-derived dendritic cells to creatine (e.g., 5 mM) versus control in nutrient-deprived media, measuring ATP concentration, surface MHC-II expression, and IL-12/IFN-γ secretion over 24–72 hours.
Mouse Model Study of Creatine Supplementation on Dendritic Cell ATP and Anti-Tumor Immunity
C57BL/6 mice with implanted melanoma tumors randomized to creatine-supplemented or control diet for 4 weeks; dendritic cells isolated from tumor-draining lymph nodes assessed for ATP content, antigen presentation, and cytokine production, with tumor growth and T-cell activation measured.